耐链霉素结核分枝杆菌分子耐药机制与表型耐药水平的相关性
Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin-resistant Mycobacterium tuberculosis.
作者信息
Meier A, Sander P, Schaper K J, Scholz M, Böttger E C
机构信息
Institut für Medizinische Mikrobiologie, Medizinische Hochschule Hannover, Germany.
出版信息
Antimicrob Agents Chemother. 1996 Nov;40(11):2452-4. doi: 10.1128/AAC.40.11.2452.
Abstract
Quantitative susceptibility testing of clinical isolates of streptomycin-resistant Mycobacterium tuberculosis demonstrated that there is a close correlation between the molecular resistance mechanism and the in vitro activity of streptomycin: mutations in rpsL were mainly associated with high-level resistance, mutations in rrs were associated with an intermediate level of resistance, and streptomycin-resistant isolates with wild-type rpsL and rrs exhibited a low-level resistance phenotype. Investigations of streptomycin-resistant isolates with wild-type rpsL and rrs revealed that (i) there is no cross-resistance to other drugs and (ii) a permeability barrier may contribute to resistance, because resistance was significantly lowered in the presence of a membrane-active agent.
摘要
对耐链霉素结核分枝杆菌临床分离株进行的定量药敏试验表明，分子耐药机制与链霉素的体外活性之间存在密切相关性：rpsL基因突变主要与高水平耐药相关，rrs基因突变与中等水平耐药相关，而具有野生型rpsL和rrs的耐链霉素分离株表现出低水平耐药表型。对具有野生型rpsL和rrs的耐链霉素分离株的研究表明：（i）对其他药物无交叉耐药性；（ii）通透性屏障可能导致耐药，因为在存在膜活性剂的情况下耐药性显著降低。
相似文献
1
Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin-resistant Mycobacterium tuberculosis.耐链霉素结核分枝杆菌分子耐药机制与表型耐药水平的相关性
Antimicrob Agents Chemother. 1996 Nov;40(11):2452-4. doi: 10.1128/AAC.40.11.2452.
2
Frequency of rrs and rpsL mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from Iranian patients.伊朗患者耐链霉素结核分枝杆菌分离株中 rrs 和 rpsL 突变的频率。
J Glob Antimicrob Resist. 2017 Jun;9:51-56. doi: 10.1016/j.jgar.2017.01.005. Epub 2017 Apr 9.
3
Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities.来自不同地理位置的耐链霉素结核分枝杆菌分离株中rpsL和rrs突变的特征分析。
Antimicrob Agents Chemother. 1996 Apr;40(4):1024-6. doi: 10.1128/AAC.40.4.1024.
4
Characterization of the rpsL and rrs genes of streptomycin-resistant clinical isolates of Mycobacterium tuberculosis in Japan.
J Appl Microbiol. 1997 Nov;83(5):634-40. doi: 10.1046/j.1365-2672.1997.00279.x.
5
GidB mutation as a phylogenetic marker for Q1 cluster Mycobacterium tuberculosis isolates and intermediate-level streptomycin resistance determinant in Lisbon, Portugal.葡萄牙里斯本 Q1 群结核分枝杆菌分离株中 GidB 突变作为系统发育标记物和中水平链霉素耐药决定因子。
Clin Microbiol Infect. 2014 May;20(5):O278-84. doi: 10.1111/1469-0691.12392. Epub 2013 Nov 4.
6
Geographic variation of the predictive values of genomic mutations associated with streptomycin resistance in Mycobacterium tuberculosis.结核分枝杆菌中与链霉素耐药相关的基因组突变预测值的地理变异。
Mol Cell Probes. 1997 Apr;11(2):123-6. doi: 10.1006/mcpr.1996.0086.
7
Characterization of streptomycin resistance mechanisms among Mycobacterium tuberculosis isolates from patients in New York City.纽约市患者结核分枝杆菌分离株中链霉素耐药机制的特征分析
Antimicrob Agents Chemother. 1996 May;40(5):1186-8. doi: 10.1128/AAC.40.5.1186.
8
Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol.耐多药结核分枝杆菌分离株对链霉素和乙胺丁醇的分子筛查与表型药敏试验
Microb Drug Resist. 2018 Sep;24(7):923-931. doi: 10.1089/mdr.2017.0294. Epub 2018 Jan 16.
9
Mutations in rrs, rpsL and gidB in streptomycin-resistant Mycobacterium tuberculosis isolates from Thailand.泰国链霉素耐药结核分枝杆菌分离株中 rrs、rpsL 和 gidB 的突变。
J Glob Antimicrob Resist. 2016 Mar;4:5-10. doi: 10.1016/j.jgar.2015.11.009. Epub 2015 Dec 15.
10
Detection of streptomycin resistance in Mycobacterium tuberculosis clinical isolates using four molecular methods in China.在中国使用四种分子方法检测结核分枝杆菌临床分离株中的链霉素耐药性。
Yi Chuan Xue Bao. 2006 Jul;33(7):655-63. doi: 10.1016/S0379-4172(06)60096-6.
引用本文的文献
1
Whole-genome sequencing for analyzing the transmission characteristics of drug-resistant Mycobacterium tuberculosis in Ganzhou, China.采用全基因组测序分析中国赣州耐多药结核分枝杆菌的传播特征。
BMC Infect Dis. 2025 Jul 28;25(1):950. doi: 10.1186/s12879-025-11356-w.
2
Antimicrobial resistance of rapidly growing mycobacteria isolated from companion animals in Taiwan.台湾地区伴侣动物中分离出的快速生长分枝杆菌的抗菌耐药性。
Microbiol Spectr. 2025 Jul;13(7):e0307424. doi: 10.1128/spectrum.03074-24. Epub 2025 May 19.
3
Heterologous production of the D-cycloserine intermediate O-acetyl-L-serine in a human type II pulmonary cell model.在人Ⅱ型肺细胞模型中 D-环丝氨酸中间产物 O-乙酰-L-丝氨酸的异源生产。
Sci Rep. 2023 May 26;13(1):8551. doi: 10.1038/s41598-023-35632-4.
4
Whole-Genome Sequencing Reveals Recent Transmission of Multidrug-Resistant CAS1-Kili Strains in Lusaka, Zambia.全基因组测序揭示了赞比亚卢萨卡耐多药CAS1-Kili菌株的近期传播情况。
Antibiotics (Basel). 2021 Dec 28;11(1):29. doi: 10.3390/antibiotics11010029.
5
Whole-Genome Sequencing of Streptomycin-Resistant Mycobacterium tuberculosis Strain SBH145 from Sabah, Malaysia.来自马来西亚沙巴的耐链霉素结核分枝杆菌菌株SBH145的全基因组测序
Microbiol Resour Announc. 2022 Jan 20;11(1):e0104021. doi: 10.1128/mra.01040-21. Epub 2022 Jan 6.
6
A novel mechanism of streptomycin resistance in Yersinia pestis: Mutation in the rpsL gene.鼠疫耶尔森氏菌链霉素耐药的新机制：rpsL 基因突变。
PLoS Negl Trop Dis. 2021 Apr 22;15(4):e0009324. doi: 10.1371/journal.pntd.0009324. eCollection 2021 Apr.
7
The roles of , , and mutations in predicting streptomycin-resistant drugs used on clinical isolates from Hebei Province, China.、和突变在中国河北省临床分离株中预测耐链霉素药物的作用。 （注：原文中部分内容缺失，可能影响完整理解。）
Int J Clin Exp Pathol. 2019 Jul 1;12(7):2713-2721. eCollection 2019.
8
Translational control of antibiotic resistance.抗生素耐药性的翻译控制。
Open Biol. 2019 Jul 26;9(7):190051. doi: 10.1098/rsob.190051. Epub 2019 Jul 10.
9
Understanding lipidomic basis of iron limitation induced chemosensitization of drug-resistant .理解铁限制诱导耐药性化疗增敏作用的脂质组学基础。
3 Biotech. 2019 Apr;9(4):122. doi: 10.1007/s13205-019-1645-4. Epub 2019 Mar 5.
10
Mechanisms of Bacterial Resistance to Antimicrobial Agents.细菌对抗菌药物耐药性的机制。
Microbiol Spectr. 2018 Jan;6(1). doi: 10.1128/microbiolspec.ARBA-0019-2017.
本文引用的文献
1
Ribosomal drug resistance in mycobacteria.分枝杆菌中的核糖体耐药性。
Res Microbiol. 1996 Jan-Feb;147(1-2):59-67. doi: 10.1016/0923-2508(96)80205-1.
2
Selective perturbation of G530 of 16 S rRNA by translational miscoding agents and a streptomycin-dependence mutation in protein S12.通过翻译错义编码剂对16 S rRNA的G530进行选择性扰动以及蛋白质S12中的链霉素依赖性突变。
J Mol Biol. 1994 Jan 7;235(1):156-72. doi: 10.1016/s0022-2836(05)80023-3.
3
Streptomycin resistance in mycobacteria.分枝杆菌中的链霉素耐药性。
Antimicrob Agents Chemother. 1994 Feb;38(2):238-42. doi: 10.1128/AAC.38.2.238.
4
Genetic alterations in streptomycin-resistant Mycobacterium tuberculosis: mapping of mutations conferring resistance.耐链霉素结核分枝杆菌的基因改变：赋予耐药性的突变图谱
Antimicrob Agents Chemother. 1994 Feb;38(2):228-33. doi: 10.1128/AAC.38.2.228.
5
The rpsL gene and streptomycin resistance in single and multiple drug-resistant strains of Mycobacterium tuberculosis.结核分枝杆菌单耐药和多耐药菌株中的rpsL基因与链霉素耐药性
Mol Microbiol. 1993 Nov;10(3):521-7. doi: 10.1111/j.1365-2958.1993.tb00924.x.
6
Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot.结核分枝杆菌中链霉素耐药性的分子基础：核糖体蛋白S12基因的改变及功能性16S核糖体RNA假结内的点突变
Mol Microbiol. 1993 Sep;9(6):1239-46. doi: 10.1111/j.1365-2958.1993.tb01253.x.
7
Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study.多重耐药对结核病短程化疗未来的影响：一项分子研究。
Lancet. 1994 Jul 30;344(8918):293-8. doi: 10.1016/s0140-6736(94)91338-2.
8
Resistance to drugs targeting protein synthesis in mycobacteria.分枝杆菌对靶向蛋白质合成的药物的耐药性。
Trends Microbiol. 1994 Oct;2(10):416-21. doi: 10.1016/0966-842x(94)90622-x.
9
10
Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis.结核分枝杆菌临床分离株中多药耐药的分子机制
J Infect Dis. 1995 Apr;171(4):954-60. doi: 10.1093/infdis/171.4.954.
Zotero 插件